BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 18991567)

  • 1. Notch signaling: a potential therapeutic target in prostate cancer.
    Villaronga MA; Bevan CL; Belandia B
    Curr Cancer Drug Targets; 2008 Nov; 8(7):566-80. PubMed ID: 18991567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Notch signaling in the prostate: critical roles during development and in the hallmarks of prostate cancer biology.
    Deng G; Ma L; Meng Q; Ju X; Jiang K; Jiang P; Yu Z
    J Cancer Res Clin Oncol; 2016 Mar; 142(3):531-47. PubMed ID: 25736982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notch signaling in prostate cancer: refining a therapeutic opportunity.
    Su Q; Xin L
    Histol Histopathol; 2016 Feb; 31(2):149-57. PubMed ID: 26521657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Notch Signaling in Cancer: Rationale and Strategies for Targeting.
    Alketbi A; Attoub S
    Curr Cancer Drug Targets; 2015; 15(5):364-74. PubMed ID: 26239151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Notch signaling in prostate cancer: a moving target.
    Carvalho FL; Simons BW; Eberhart CG; Berman DM
    Prostate; 2014 Jun; 74(9):933-45. PubMed ID: 24737393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Notch promotes tumor metastasis in a prostate-specific Pten-null mouse model.
    Kwon OJ; Zhang L; Wang J; Su Q; Feng Q; Zhang XH; Mani SA; Paulter R; Creighton CJ; Ittmann MM; Xin L
    J Clin Invest; 2016 Jul; 126(7):2626-41. PubMed ID: 27294523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HES6 promotes prostate cancer aggressiveness independently of Notch signalling.
    Carvalho FL; Marchionni L; Gupta A; Kummangal BA; Schaeffer EM; Ross AE; Berman DM
    J Cell Mol Med; 2015 Jul; 19(7):1624-36. PubMed ID: 25864518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Notch signaling proteins: legitimate targets for cancer therapy.
    Wang Z; Li Y; Sarkar FH
    Curr Protein Pept Sci; 2010 Sep; 11(6):398-408. PubMed ID: 20491628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Notch and its oncogenic signaling crosstalk in breast cancer.
    Guo S; Liu M; Gonzalez-Perez RR
    Biochim Biophys Acta; 2011 Apr; 1815(2):197-213. PubMed ID: 21193018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological inhibition of the Notch pathway enhances the efficacy of androgen deprivation therapy for prostate cancer.
    Cui J; Wang Y; Dong B; Qin L; Wang C; Zhou P; Wang X; Xu H; Xue W; Fang YX; Gao WQ
    Int J Cancer; 2018 Aug; 143(3):645-656. PubMed ID: 29488214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational targeting of Notch signaling in cancer.
    Rizzo P; Osipo C; Foreman K; Golde T; Osborne B; Miele L
    Oncogene; 2008 Sep; 27(38):5124-31. PubMed ID: 18758481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Notch signaling: an emerging therapeutic target for cancer treatment.
    Yuan X; Wu H; Xu H; Xiong H; Chu Q; Yu S; Wu GS; Wu K
    Cancer Lett; 2015 Dec; 369(1):20-7. PubMed ID: 26341688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NOTCH and PTEN in prostate cancer.
    Bertrand FE; McCubrey JA; Angus CW; Nutter JM; Sigounas G
    Adv Biol Regul; 2014 Sep; 56():51-65. PubMed ID: 24933481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear hormone receptor signals as new therapeutic targets for urothelial carcinoma.
    Miyamoto H; Zheng Y; Izumi K
    Curr Cancer Drug Targets; 2012 Jan; 12(1):14-22. PubMed ID: 22111835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emodin inhibits the proliferation of PC3 prostate cancer cells in vitro via the Notch signaling pathway.
    Deng G; Ju X; Meng Q; Yu ZJ; Ma LB
    Mol Med Rep; 2015 Sep; 12(3):4427-4433. PubMed ID: 26081222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic targeting of Notch signaling in cancer].
    Brahmi M; Bally O; Eberst L; Cassier P
    Bull Cancer; 2017 Oct; 104(10):883-891. PubMed ID: 29031504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NUMB inhibition of NOTCH signalling as a therapeutic target in prostate cancer.
    Belle VA; McDermott N; Meunier A; Marignol L
    Nat Rev Urol; 2014 Sep; 11(9):499-507. PubMed ID: 25134838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia, notch signalling, and prostate cancer.
    Marignol L; Rivera-Figueroa K; Lynch T; Hollywood D
    Nat Rev Urol; 2013 Jul; 10(7):405-13. PubMed ID: 23712204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Notch signaling in serous ovarian cancer.
    Groeneweg JW; Foster R; Growdon WB; Verheijen RH; Rueda BR
    J Ovarian Res; 2014 Nov; 7():95. PubMed ID: 25366565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin induces G0/G1 arrest and apoptosis in hormone independent prostate cancer DU-145 cells by down regulating Notch signaling.
    Sha J; Li J; Wang W; Pan L; Cheng J; Li L; Zhao H; Lin W
    Biomed Pharmacother; 2016 Dec; 84():177-184. PubMed ID: 27657825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.